• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH
Click for more information
0.00% 0.5¢

ALTERITY THERAPEUTICS LIMITED - Corporate Spotlight

Market Cap $26.22M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company’s lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson’s disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase 2 clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
0.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $26.22M
Open High Low Value Volume
0.6¢ 0.6¢ 0.5¢ $26.81K 4.868M

Buyers (Bids)

No. Vol. Price($)
45 42771258 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 20563308 22
View Market Depth
Last trade - 16.10pm 15/05/2024 (20 minute delay) ?
Last
0.5¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
0.5¢ 0.6¢ 0.5¢ 1735805
Last updated 13.27pm 15/05/2024 ?
ATH (ASX) Chart

Top Stories

Want copper with that? Boss Energy hits orange metal on-site uranium play

The exploration team at Boss Energy announced on Wednesday that its latest drill run on-site has successfully found copper.
Market Close: Materials win on critical minerals, hydrogen budget promises Renascor Resources (ASX:RNU) was the biggest winner gaining 30 per cent without market news, while Chalice Mining (ASX:CHN), Vulcan Energy Resources (ASX:VUL) and Aeris Resources (ASX:AIS) all gained between 7 and 10 per cent.
Recce Pharma heading closer to full efficacy data for flagship R327 Recce Pharma has announced the latest cohort of patients in the company's Phase I/II UTI trial has been dosed.
Is IPO mania back for the ASX? Sun Silver jumps 100% on first day of listing Sun Silver is enjoying a strong debut on the local bourse with shares up 100% to 40cps as miners enjoy budgetary stimulus.
Retail Revolution: Shekel Brainweigh leads the charge in Digital Inventory Management Industry specialist Shekel Brainweigh (ASX:SBW) has built AI into its high-tech product scale and weighing technologies.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.